7/24/2024  10:48:35 PM Chg. -12.08 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
74.96USD -13.88% 100,052
Turnover: 8.7 mill.
-Bid Size: - -Ask Size: - 52.4 bill.USD - 37.64

Business description

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.
 

Management board & Supervisory board

CEO
Bernard J. Zovighian
Management board
Scott B. Ullem, Donald E. Bobo Jr., Todd J. Brinton, Daveen Chopra, Dirksen J. Lehman, Jean-Luc Lemercier, Wayne Markowitz, Christine Z. McCauley, Joseph Nuzzolese
Supervisory board
Michael A. Mussallem, Kieran T. Gallahue, Leslie S. Heisz, Martha H. Marsh, Nicholas J. Valeriani, Paul A. LaViolette, Ramona Sequeira, Steven R. Loranger, Bernard J. Zovighan
 

Company data

Name: Edwards Lifesciences Corp.
Address: One Edwards Way,Irvine, California 92614, USA
Phone: +1-949-250-2500
Fax: -
E-mail: -
Internet: www.edwards.com/
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 83.04%
IPO date: 4/3/2000

Investor relations

Name: Mark Wilterding
IR phone: +1-949-250-6826
IR Fax: -
IR e-mail: investor_relations@edwards.com